Search Results 1151-1160 of 18473 for Immunode

1. A Study Comparing Vaccinia Virus Based Immune System Therapy Plus Sorafenib versus Sorafenib Alone to Treat Liver Cell Cancer - Mayo Clinic

   Known significant immunodeficiency due to underlying illness (e.g., HIV/AIDS) and/or immune-suppressive medication including high-dose corticosteroids ...

2. A Study of STRO-001 in Patients with Advanced B-Cell Malignancies - Mayo Clinic

   Known Human Immunodeficiency Virus seropositivity. Positive serology for hepatitis B defined by a positive test for HBsAg. Concurrent participation in ...

3. A Study to Evaluate the Effectiveness, Safety and Way in Which the Body Processes REGN3500 in Adults with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

   History of human immunodeficiency virus (HIV) infection or positive HIV serology at screening. Positive with hepatitis B surface antigen (HBsAg), hepatitis ...

4. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy are ineligible; patients must also have a CD4 count > 350 cells ...

5. Sofosbuvir/GS-5816 Fixed-Dose Combination in Adults with Chronic HCV Infection and Child-Pugh Class B Cirrhosis - Mayo Clinic

   Infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV); Screening ECG with clinically significant abnormalities; Prior exposure to SOF ...

6. A Study to Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Patients positive for human immunodeficiency virus (HIV) are allowed on study, but HIV-positive patients must have: A stable regimen of highly active anti ...

7. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) - Mayo Clinic

   Diagnosis of immunodeficiency or receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the first dose of ...

8. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

   Men or women of childbearing potential who are unwilling to employ adequate contraception. Known human immunodeficiency virus or acquired immunodeficiency ...

9. A Study Of Sotatercept For The Treatment Of Pulmonary Arterial Hypertension - Mayo Clinic

   History of human immunodeficiency virus infection-associated PAH. Prior exposure to sotatercept (ACE-011) or luspatercept (ACE-536). Uncontrolled systemic ...

10. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    Subjects with a known human immunodeficiency virus (e.g., HIV), other than that explained by the use of OCS or other therapy taken for HES. Other laboratory ...